Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
Crossref DOI link: https://doi.org/10.1007/s12020-014-0461-1
Published Online: 2014-10-28
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mabilleau, Guillaume
Text and Data Mining valid from 2014-10-28